Died; This is a spontaneous report received from a consumer. An adult male patient received BNT162b2 Omicron (KP.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient’s relevant medical history included: “Hospitalization” (ongoing). The patient took concomitant medications. The patient received other medications in two weeks. Vaccination history included: COVID-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; COVID-19 vaccine (DOSE NUMBER UNKNOWN (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunization. No other vaccine was administered in four weeks or on the same date of the suspect COVID-19 vaccine. The following information was reported: DEATH (death, prolonged hospitalization, disability, life threatening, medically significant), outcome “fatal”, described as “Died”. Therapeutic measures were taken as a result of death. The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. The patient’s child was doing this for the patient as he died from getting the COVID-19 vaccines and boosters. The adverse events resulted in death, prolongation of existing hospitalization (treatment received during existing hospitalization), life-threatening illness (immediate risk of death from the event), and disability or permanent damage. Per patient’s child, the patient did not recover from the event. The information on the batch/lot number for BNT162b2 Omicron (KP.2) will be requested and submitted if and when received.; Reported Cause(s) of Death: Died